Cited by 576T-cell and B-cell ImmunologyCancer Immunotherapy and BiomarkersMitochondrial Function and Pathology

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen

Open access

Vardhana, Santosha A., Hwee, Madeline A., Berisa, Mirela, Wells, Daniel K., Yost, Kathryn E., King, Bryan, Smith, Melody, Herrera, Pamela S., Chang, Howard Y., Satpathy, Ansuman T., van den Brink, Marcel R. M., Cross, Justin R., Thompson, Craig B.·2020·Nature Immunology

DOI 10.1038/s41590-020-0725-2PMC PMC7442749

Open this paper in CoChat — free account

Abstract

The majority of tumor-infiltrating T cells exhibit a terminally exhausted phenotype, marked by a loss of self-renewal capacity. How repetitive antigenic stimulation impairs T cell self-renewal remains poorly defined. Here, we show that persistent antigenic stimulation impaired ADP-coupled oxidative phosphorylation. The resultant bioenergetic compromise blocked proliferation by limiting nucleotide triphosphate synthesis. Inhibition of mitochondrial oxidative phosphorylation in activated T cells was sufficient to suppress proliferation and upregulate genes linked to T cell exhaustion. Conversely, prevention of mitochondrial oxidative stress during chronic T cell stimulation allowed sustained T cell proliferation and induced genes associated with stem-like progenitor T cells. As a result, antioxidant treatment enhanced the anti-tumor efficacy of chronically stimulated T cells. These data reveal that loss of ATP production through oxidative phosphorylation limits T cell proliferation and effector function during chronic antigenic stimulation. Furthermore, treatments that maintain redox balance promote T cell self-renewal and enhance anti-tumor immunity. Thompson and colleagues show that repetitive antigenic stimulation within the tumor environment triggers mitochondrial dysfunction by inhibiting oxidative phosphorylation, which leads to T cell exhaustion.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41590-020-0725-2

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Self-citation
The Molecular Signatures Database Hallmark Gene Set Collection
Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.004 · Cited by 13,807
On the origin of cancer cells
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Cancer immunotherapy using checkpoint blockade
Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Mariathasan, S., Turley, S. J., Nickles, D., Castiglioni, A., Yuen, K., Wang, Y., Kadel III, E. E., Koeppen, H., Astarita, J. L., Cubas, R., et al. (2018) · Nature · doi:10.1038/nature25501 · Cited by 5,400
Molecular and cellular insights into T cell exhaustion
Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652
Cellular response to oxidative stress: Signaling for suicide and survival*
Martindale, J. L., & Holbrook, N. J. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10119 · Cited by 2,314

Show all 67 references

Sorted by citations

Items 501–576 of 576

Tumor cell spheroid-induced suppression of primary human cytotoxic T cells as a scalable in vitro model of exhaustion
Alsubaiti, A., Alamir, H., Huynh, L., Grant, T., Aljohani, A., Chou, P. H., Shi, Y., Alismail, M., Mason, L. R., Herman, A., et al. (2024) · Immunotherapy Advances · doi:10.1093/immadv/ltaf023 · Cited by 1
Immunometabolism Governs T Cell Immunity
Raynor, J. L., Shi, H., & Chi, H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00275-1
Systematic growth factor profiling platform for 3D tumor models reveals estradiol-responsive cellular mechanisms of immunotherapy resistance
Lee, K., Kim, M., Lim, S. O., Shin, D.-J., Shin, Y., Choi, J.-J., Lee, J. W., Kang, H. J., Lee, J. W., & Lee, K. (2025) · Biofabrication · doi:10.1088/1758-5090/ae26cc
Single-cell multiomics reveals epigenetic rewiring of splenic memory B cells in murine malaria reinfectionPreprint
Coronado, M., Vincelle-Nieto, Á., Azcárate, I. G., Pérez-Benavente, S., Puyet, A., Díez, A., Bautista, J. M., & Reyes‐Palomares, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.10.693423
Viral transduction for T cell engineering in immunotherapy
Seo, Y., Pak, J., Han, J., Bae, J., & Hwang, S. S. (2026) · Molecules and Cells · doi:10.1016/j.mocell.2026.100311
Mitochondrial function of peripheral lymphocytes: role on multiple sclerosis clinical subtypes
González‐Jiménez, A., de Heras-Pino, P., Moreno-Jerez, A., Mena-Plaza, E., Aladro, Y., Pilo, B., Celia, O.-G., Gómez-Estévez, I., López‐Pastor, A. R., Delgado, I. G., et al. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124196
Multiplexed high-content imaging uncovers morphological diversity of lymphocyte activation and dysfunctionPreprint
Matte, J. C., Bakker, O. B., Ohl, M., Cisternino, F., Manrique-Rincón, A., Husmann, A., Lichou, F., Tong, L. I., Kwakwa, K., Speak, A. O., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.10.704860
Functional Type I and Type II interferon crosstalk restricts progenitor exhausted CD8 T cells through spatial exclusion and checkpoint enforcementPreprint
Liu, S., Elsaesser, H. J., Quevedo, R. V., Abd-Rabbo, D., Bertol, B. C., Xu, W., Liu, M. Y. R., Lukhele, S., Lamorte, S., McGaha, T. L., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.01.708869
Detection of mitochondrial DNA mutations in T cells following 5-FU or cisplatin exposure
Kirkpatrick, C. A., Quick, C. M., Post, S. R., Leung, Y., Dings, R. P. M., Paulos, C. M., Burdine, L., & Lu, Y.-C. W. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102663
Metabolic Constraints and Interactions Drive T-cell Function and Exhaustion in Cancer Progression
Tzeng, S., & Tsai, C.-H. (2026) · Journal of Medical Sciences · doi:10.4103/jmedsci.jmedsci_234_25
Mitochondrial ATP production promotes T cell differentiation and function by regulating chromatin accessibilityPreprint
Ng, C., Fung, T. S., Li, D., Kropp, K. N., Patterson, L. F. S., Markovitz, A., Weinberg, D. N., Jones, O., Kim, J.-Y., Zhang, G., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.27.714789
Self-citation
Nebivolol prevents exhausted T cells and enhances cytotoxicity against MCF-7 breast cancer cells in a β2-adrenergic receptor-dependent manner
Hajiaghayi, M., Gholizadeh, F., Rahbari, N., Emamnia, N., Shih, S. C. C., & Darlington, P. J. (2026) · Clinical & Experimental Immunology · doi:10.1093/cei/uxag018
Pharmacologic DPP-4 inhibition promotes CD8⁺ T cell metabolic fitness to enhance anti-tumor activityPreprint
Pumar, O. T., VanNoy, E. L., Haffey, A., Gannamedi, D. P., Rafie, C. I., Harwood, D. S. L., Benedetti, J. R., Ballard, C. A. P., Ciervo, E., Coroa, P. H. A. T., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.31.715681
Leveraging a Multienzymes‐Mimicking Nanozyme to Overcome CDK4/6 Inhibitor Resistance and Achieve Drug Repurposing in Oesophageal Squamous Cell Carcinoma
Wu, P., Lan, L., Li, Z., Shakir, I., Zhou, J., Yao, Y., Ying, B., Zhou, J., Sun, X., Li, Y., et al. (2026) · Small · doi:10.1002/smll.202514464
Contrôle des fonctions lymphocytaires T pour l'optimisation des immunothérapies cellulaires anti-tumorales
Mercier‐Letondal, P. (2025) · theses.fr (ABES) · doi:10.70675/fb692847z0188z4b0czaf29za1e4d337e717
T Cell exhaustion: a signal written in heme
Han, W. (2026) · Blood Science · doi:10.1097/bs9.0000000000000290
Low NDFIP1-driven metabolic alterations in CD8 + T cells: implications for immune evasion and therapy resistance in HNSC
Wan, J., Zhou, Y., Xie, D., Chen, Z., Yang, D., Tang, Y., Zuo, Y., Luo, D., & Wang, L. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04304-4
Cristae Architecture as a Metabolic Checkpoint in Effector T Cells — Implications for Cancer Immunity
Jeysankar, P., Srikanth, S., Wu, B., & Gwack, Y. (2026) · Journal of Cancer Immunology · doi:10.33696/cancerimmunol.8.120
Regulatory heme: a mitochondria-to-nucleus messenger of CD8+ T-cell exhaustion
Song, H., Shi, H., & Chi, H. (2026) · Cellular and Molecular Immunology · doi:10.1038/s41423-026-01420-z
Redox index and capacity analysis (RICA) reveals NAD biology changes in T cell responses in vitro and ex vivo
Bostwick-Galaviz, A. M., & Usherwood, E. J. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag035
Comprehensive analysis of ATF3 as a diagnostic and prognostic biomarker from pan-cancer to clear cell renal cell carcinoma
Ling, H., Wu, G., & Hu, Y. (2026) · Discover Oncology · doi:10.1007/s12672-026-05113-x
Mitochondrial metabolism as a pharmacological target for cancer therapeutics
Yu, Y., Ding, W., Liu, S., Glorieux, C., Liu, P., & Huang, P. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100137
Blocking mitochondrial leucine transamination enhances T-cell activation and improves T-cell immunity against OVA-producing EL4 lymphoma
Adam, C. M., Wetzel, T. J., Erfan, S. C., Wheeler, L. M., Baer, E. E., Croll, L., Martin, A. M., Khan, T. Z., Swain, M., Boyer, M. P., et al. (2026) · British Journal of Cancer · doi:10.1038/s41416-026-03455-5
Transfer RNA Fragments in Diseases of Sensory Organs
Gulati, N., Yang, Z., Lin, Y. X., Sanusi, H., Gonda, B. L., McNally, D. C., Stellwag, A., Holmes, M., Chaudhary, R., Stevenson, J., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27094142
Drug Delivery Engineering Strategies Targeting CD4+/CD8+ T Cell Exhaustion to Improve the Tumor Immunosuppressive Microenvironment
Yue, J., Chen, M., Xiong, Z., Qiu, J., Liu, Y., & Chen, L. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s595199 · Cited by 1
Nutrient-driven immunometabolism in metabolic disease
Kousar, S., Arshad, T., & Waseem, M. (2026) · Exploration of Endocrine and Metabolic Diseases · doi:10.37349/eemd.2026.101472
Future directions in the treatment of brain metastases: evaluating the role of cellular players in the tumour microenvironment
Govaerts, C. W., van Dijk, J. M. C., van der Hoorn, A., & Kruyt, F. A. E. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-03011-8
Optimization of a parallel CAR for B-cell lymphoma via ITAM attenuation and target specificity validation
Kausar, F., Davis, C., Larcombe-Young, D., Bove, C., Farzaneh, F., Graham, C., Benjamin, R., Davies, D. M., & Maher, J. (2026) · Clinical & Experimental Immunology · doi:10.1093/cei/uxag032
Yam Protects Immunocompromised Mice from Influenza Infection via the Gut–SCFA–GPCR–Immune Axis
Li, Q., Qu, X., Li, M., Song, Y., Xu, Q., Wang, Q., Dong, H., Wang, X., & Liu, Q. (2026) · Nutrients · doi:10.3390/nu18111793
Nanomedicine orchestrated metabolic reprogramming of immune cells in antitumor immunity
Lin, A., Chen, Y., Liu, J., Jiang, A., Zhu, W., Cheng, Q., Zhang, J., Yuan, Q., Mao, W., & Luo, P. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218586
Mitochondrial dynamics and T cells immunity in cancer
Li, X., Zhang, M., Wang, Y., Li, M., Wang, T., & Liu, X. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102659
Glutamine-driven mTORC1 activity enforces glycolytic bias, hyperactivation and aberrant proliferation in T cells in chronic B-cell leukemiaPreprint
Goedhart, N. B., Camerini, E., Cretenet, G., Grootemaat, A. E., Vlaskov, K., Jacobs, C. F., d’Hargues, Y., van der Wel, N. N., Vrieling, F., Schomakers, B. V., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.09.731122
Mitochondrial transfer between tumor and immune cells: a nexus of metabolic adaptation and immune dysfunction
Yang, J., Li, Y., Kumar, S. V., Saba, N. F., Shay, C., & Teng, Y. (2026) · Biomarker Research · doi:10.1186/s40364-026-00955-7
Targeting TMED4 enhances CD8 + T cell function and CAR T cell efficacy in solid tumors through the IRE1α-autophagy axis
Wang, H., Shi, L., Jiang, K., Wu, S., Jiang, Z., Tao, Y., Li, J., Liu, J., Liu, J., Ni, J., et al. (2026) · Science Advances · doi:10.1126/sciadv.aee0517
Block, clear, and boost: a novel therapeutic framework for targeting intercellular mitochondrial transfer in Cancer immunotherapy
Liu, R., Yang, Y., Wang, Z., Hu, Z., Yang, L., Guo, R., & Wang, H. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117027
Small Molecule Activators of Antitumor Immunity
Singh, V. P., & Uesugi, M. (2026) · Accounts of Chemical Research · doi:10.1021/acs.accounts.6c00316
STAT1 Serotonylation Remodels CD8+ T Cell Mitochondrial Function to Potentiate Antitumor Efficacy of PD-1 BlockadePreprint
Lü, S., Meng, D., Lu, W., Jiang, C., Sun, R., Chen, Y., Ji, P., Xia, L., & Wang, Y. (2026) · Research Square · doi:10.21203/rs.3.rs-10006071/v1
From exhaustion to functional cure: frontiers in reversing HBV-specific T-cell immunity
Liang, L., Xie, X., He, S., Zhou, L., & Yue, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1877059
ST6GAL1 Glycoengineering Rewires Cytokine Signaling and Preserves Metabolic Fitness in CAR-T Cells Under Galectin-3-Mediated Immunosuppression
Lau, L. S., Suarez, M., Berdalinova, A., Fan, R. Z., Shil, R. K., Souchak, J., Tieu, K., Posey, A. D., & Dimitroff, C. J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146393
Nicotinamide riboside tunes adoptive T cells for memory and metabolic fitness
Dai, Z. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.07.010
Integrating T cell signaling and metabolism to enhance T cell engager responses in solid tumors
Scaglione, M., Engavale, M. B., Chun, M. G. H., Sawant, D. V., Lu, D., & LaGory, E. L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1887842
HPV-driven metabolic reprogramming promotes T cell exhaustion: targeting immunometabolic barriers with natural products
Wei, L., Menghui, H., Zhang, D. J., Wang, X. G., Chu, X., Guangyi, 马. M., & Jing, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1892919
Non-redundant functions of NFATc1 in survival and NFATc2 in generation of exhausted CD8+ T cells
Sampere-Birlanga, S., Klein‐Hessling, S., Prados, M. C., Huang, A., Wu, H., Rosenwald, A., Kastenmüller, W., Serfling, E., Vaeth, M., & Berberich‐Siebelt, F. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1869029
ATP-Red enables single-cell bioenergetic phenotyping by flow cytometry
Franco, J. L. M., Singh, B., Fuchs, A. L., Tarasenko, T. N., Warren, E. B., Kirby, M., Anderson, S. M., Wincovitch, S., Gordon‐Lipkin, E. M., Kruk, S., et al. (2026) · Cell Reports Methods · doi:10.1016/j.crmeth.2026.101537
CAR-T in solid tumors: Obstacles and potential strategies
Ding, Z., Li, Y., & Huang, M. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.07.047
Mitochondrial metabolism and PD-1 blockade: mechanisms and therapeutic opportunities in cancer immunotherapy
Asl, K. D., Kalarestaghi, H., Rafat, A., Bahramloo, M., Shahabi, S. A., Mollayousefi, H. S., Moosavi, S. S., & Mazloumi, Z. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12519-x
Metabolic rewiring of the dendritic cell–T cell axis: tumour-derived barriers and therapeutic opportunities
Cho, M., & Song, M. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01798-w
Predictive value of preoperative T cell phenotypes for postoperative pulmonary complications in elderly patients undergoing thoracic surgery
Liu, W., Liu, Y., Zhou, T., Zhao, X., Yang, J., Liu, Q., & Ji, M. (2026) · Journal of Anesthesia and Translational Medicine · doi:10.1016/j.jatmed.2026.07.002
The cost of persistence: MEK and metabolic demand
Sobierajska, E., & Medina, C. B. (2026) · Immunity · doi:10.1016/j.immuni.2026.07.012
Coupling redox regulation with Cancer immunotherapy: The challenge of polyphenol Nanocarriers
Curcio, M., Saletta, F., Scorzafave, L., Fiore, M., Nicoletta, F. P., Iemma, F., Vittorio, O., & Cirillo, G. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115956
Single-Cell RNA Sequencing Reveals T-Cell Metabolic Activation and SGPL1 as a Candidate Predictor of PD-1 Resistance in Urothelial Carcinoma
Chao, Z., Mei, Y., Peng, H., Li, G., Hao, X., Liu, Y., Lyu, G., Wang, Z., & Li, L. (2026) · Pharmaceuticals · doi:10.3390/ph19081284
Research Progress of T Lymphocyte Autophagy in Anti-Tumor Immunotherapy
时, 拥. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1682970
T-cell activation profiles predict outcomes of neoadjuvant therapy in breast cancer
Cai, C., Huang, J., Li, J., 郑赛香, Lin, D., Duan, C., & Xu, Y. (2026) · Clinical Immunology · doi:10.1016/j.clim.2026.110762
Single-cell transcriptomic signatures of T cells associated with rituximab responsiveness in idiopathic nephrotic syndrome
Ito, E., Watanabe, Y., Onogi, C., Horinouchi, A., Ogami, K., Yoshino, S., Sugimoto, Y., Komatsu, S., Tanaka, A., Furuhashi, K., et al. (2026) · iScience · doi:10.1016/j.isci.2026.117237
Cytotoxic CD4+ T cells induce age-associated myelopoiesis through CCL5–CCR5 signaling
Gabandé‐Rodríguez, E., Soto‐Heredero, G., Carrasco, E., Anerillas, C., Escrig-Larena, J. I., Martínez-Cano, J., Delgado-Pulido, S., Francos-Quijorna, I., Desdín-Micó, G., Смирнова, Т. А., et al. (2026) · Nature Aging · doi:10.1038/s43587-026-01209-9 · Cited by 2
Stem-like CD4 T cells in tumors: an emerging framework for antitumor immunity
Xu, J., Yang, Y., Zhang, J., & Zhang, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1853163
Decoding T cell exhaustion in the tumour microenvironment
Park, J. A., Im, J., & Hwang, S.-M. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01809-w · Cited by 2
Tumors steal a signal from T cells
Chandel, N. S. (2026) · Science · doi:10.1126/science.aek5854
From cellular therapy to biologics: Non-viral delivery strategies for in vivo CAR-T engineering
Wu, S., Shen, Y., Tong, X., Nian, S., & Yang, P. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105587
Boosting T cell antioxidant capacity: A strategic approach to overcome immunosuppression in solid tumors
Fan, L., Pang, Y., Wang, L., Kechiyerunda, D. C., Zhang, B., & Liang, J. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104388
Mitochondrial ATP promotes T cell differentiation through chromatin accessibility
Ng, C., Fung, T. S., Li, D., Kropp, K. N., Patterson, L. F. S., Markovitz, A., Weinberg, D. N., Jones, O., Kim, J.-Y., Zhang, G., et al. (2026) · Cell · doi:10.1016/j.cell.2026.08.023
Self-citation
Targeting Mitochondrial Metabolic Reprogramming: Reversing CD8⁺ T Cell Exhaustion and Improving Cancer Immunotherapy Response
Liu, G., Wang, J., Vasiukevich, A. M., Feng, B., & An, L. (2026) · Biology and Medical Engineering · doi:10.63808/bm.v2i1.531
Mitochondrial dysfunction as a metabolic checkpoint of immunotherapy response in colorectal cancer
Tomassini, L., Colella, M., Monteleone, G., Stolfi, C., & Laudisi, F. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1908222
Cascades From Caspase‐Dependent Osteoblast Death to Purinergic Signaling in the Pathogenesis of Osteoporosis: Novel Roles of Caspases in Bone Remodeling
Xu, S., Wang, Y., Li, W., Lu, F., Xue, Y., Wang, J., Liang, D., & Tao, L. (2026) · Comprehensive physiology · doi:10.1002/cph4.70270
TFAM Dependent Mitochondrial Fitness Limits CD8⁺ T Cell Immunopathology and Sustains Protective Immunity during Viral PneumoniaPreprint
Navaeiseddighi, Z., Guo, K., HASAN, S. S., Wang, Z., Mishra, R., Schmit, T., Ahsan, J., Moser, E. J., Hur, J., Yount, J. S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.24.754254
The Cardio-Onco-Immune Axis: immunopathological mechanisms in the cardiac microenvironment of checkpoint inhibitor-induced myocarditis
Liang, L.-K., Ye, Q., Li, J., Shi, L.-Y., Wang, S.-P., Liang, W.-J., Chen, A., & Feng, G. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01947-x
Mitochondrial fitness in circulating T cells predicts neoadjuvant therapy response in locally advanced colorectal cancer
Huang, S., Fu, Y., Bai, F., Cai, R., Zhang, J., Qin, G., Wu, Z., Wu, Y., Zhan, W., Qi, S., et al. (2026) · Gastroenterology report · doi:10.1093/gastro/goag099
Altered OXPHOS potential in ascites immune cells is linked to CD4 T-cell exhaustion and a higher risk of spontaneous bacterial peritonitis in cirrhosis
Cosgun, H. T., Kumar, P., Zhang, I. W., Hammerich, L., Sudheer, V., Pavlidis, C., Wang, J., Schwarz, H., Tacke, F., Canbay, A. E., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1853973
A signaling-optimized TIGIT chimeric switch receptor promotes metabolic fitness and antitumor efficacy of TCR/CAR T cellsPreprint
Ferreira, E. A., Legscha, K. J., Schmits, U. R., Reinbrecht, A., Theobald, M., & Echchannaoui, H. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.02.755760
Mitochondrial orchestration of melanoma: A nexus of metabolism, immunity, and therapeutic vulnerability
Kłos, P., & Dabravolski, S. A. (2026) · Mitochondrion · doi:10.1016/j.mito.2026.102224
T-cell metabolic reprogramming in systemic lupus erythematosus: linking intracellular metabolism to effector differentiation and senescent-like/exhausted-like states
邹毅, Ren, Z., Kudo, Y., & Kono, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1961063
CRISPR-Cas9 screen identifies eIF4G2 as a regulator of CD8+ T cell dysfunction
Holcomb, E. A., Jiang, L., Pearson, A. N., James, J., Tate, A., Wang, Z., Dasgupta, A., Clauwaert, J., Armas, N. D., Elaimy, A. L., et al. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag187
Targeting myeloid cell plasticity and metabolic reprogramming to alleviate T cell dysfunction and exhaustion-associated states and enhance immune checkpoint blockade therapy
Wang, M., Chen, J., 吴中华, Wang, Z., Zhong, Z., & Zhong, Y. (2026) · Biomarker Research · doi:10.1186/s40364-026-01011-0
Dynamic Expression Quantitative Trait Locus Mendelian Randomization in Activated CD4‐Positive T Cells Nominates SMDT1 and CMTM7 as Candidate Genes in Pancreatic Cancer
Wang, H., Wang, B., Duan, X., Jiao, G., Chen, M., Guan, X., Cao, J., Cui, L., Li, H., & Li, Z. (2026) · Molecular Carcinogenesis · doi:10.1002/mc.70198
Redox Reprogramming of the Tumor Microenvironment: Targeting Extracellular ROS to Restore Antitumor Immunity
Xu, Z., Wang, L., Zhang, J., He, Y., & Wang, J. (2026) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6c00362
Mitochondrial Fitness in Anti-Tumor T Cells: From Activation to Exhaustion and Memory Formation
Lee, D.-K., & Seo, J. H. (2026) · Biomolecules · doi:10.3390/biom16111539

Authors: Vardhana, S. A., Hwee, M. A., Berisa, M., Wells, D. K., Yost, K. E., King, B., Smith, M., Herrera, P. S., Chang, H. Y., Satpathy, A. T., van den Brink, M. R. M., Cross, J. R., & Thompson, C. B.
Affiliations: Memorial Sloan Kettering Cancer Center (US)
Parker Institute for Cancer Immunotherapy (US)
Stanford Medicine (US)
Howard Hughes Medical Institute (US)
Corresponding author: Thompson, Craig B.
ORCID: Vardhana, Santosha A.
Berisa, Mirela
Wells, Daniel K.
Yost, Kathryn E.
King, Bryan
Smith, Melody
Chang, Howard Y.
Satpathy, Ansuman T.
Cross, Justin R.
Thompson, Craig B.
Venue: Nature Immunology
Publisher: Springer Science and Business Media LLC
Published: 2020-07-13
Volume: 21
Issue: 9
Pages: 1022-1033
ISSN: 1529-2908 (ISSN-L)
1529-2916
DOI: 10.1038/s41590-020-0725-2
PMC: PMC7442749
OpenAlex: W3040911066
Semantic Scholar: 0e26544b84036d0da9a73a3a38337fc7b1573819
Cited by: 575
References: 67
Citations by year: 2026: 133 · 2025: 117 · 2024: 112 · 2023: 90 · 2022: 68 · 2021: 46 · 2020: 9
FWCI: 18.62
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature Immunology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: Howard Hughes Medical Institute
National Institutes of Health (1r01hl147584-01a1)
National Heart, Lung, and Blood Institute (R01‐HL147584)
National Cancer Institute (K08CA237731, P30CA008748)
National Institute of Allergy and Infectious Diseases (R25AI140472)
Topics: Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords: T cell exhaustion, mitochondrial oxidative phosphorylation, T cell self-renewal, chronic antigenic stimulation, T cell proliferation, mitochondrial oxidative stress, antioxidant treatment, redox homeostasis, tumor-infiltrating T cells, antitumor immunity
MeSH terms: Cell Self Renewal, Adenosine Diphosphate, Animals, Antigens, Neoplasm, Antioxidants, Energy Metabolism, Immune Tolerance, Lymphocyte Activation, Melanoma, Experimental, Mice, Inbred C57BL, Mitochondria, Neoplasms, Oxidative Phosphorylation, Lymphocytes, Tumor-Infiltrating, Clonal Anergy, CD8-Positive T-Lymphocytes, Cell Proliferation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks